Access to Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma
Crossref DOI link: https://doi.org/10.1007/s12325-021-01838-z
Published Online: 2021-07-23
Published Print: 2021-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Snyder, Sophie http://orcid.org/0000-0003-2684-2962
Chung, Karen C.
Jun, Monika P.
Gitlin, Matthew
Funding for this research was provided by:
Bristol-Myers Squibb
Text and Data Mining valid from 2021-07-23
Version of Record valid from 2021-07-23
Article History
Received: 1 April 2021
Accepted: 21 June 2021
First Online: 23 July 2021